|
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
RECRUITINGPhase 3Sponsored by Aura Biosciences
Actively Recruiting
PhasePhase 3
SponsorAura Biosciences
Started2023-12-06
Est. completion2027-11-15
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations36 sites
View on ClinicalTrials.gov →
NCT06007690
Summary
The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma (CM).
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Clinical diagnosis of primary indeterminate lesion or small choroidal melanoma (IL/CM) * Have no evidence of metastatic disease confirmed by imaging * Be treatment naive for IL/CM (subjects who received PDT may be eligible) Exclusion Criteria: * Have known contraindications or sensitivities to the study drug or laser * Active ocular infection or disease
Conditions5
CancerChoroidal MelanomaIndeterminate LesionsOcular MelanomaUveal Melanoma
Interventions1
Locations36 sites
Retina Consultants of Alabama
Birmingham, Alabama, 35233
UCSD Shiley Eye Institute, Jacobs Retina Center
Doris Stein Eye Research Center
Stanford University School of Medicine
Retinal Consultants Medical Group, Inc.
Find trials near these locations
Cancer trials in Los AngelesCancer trials in SacramentoCancer trials in MiamiCancer trials in TampaCancer trials in AtlantaCancer trials in ChicagoCancer trials in BostonCancer trials in OmahaCancer trials in New YorkCancer trials in ClevelandCancer trials in Oklahoma CityCancer trials in PhiladelphiaAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in MassachusettsAll trials in MinnesotaAll trials in MissouriAll trials in NebraskaAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in OklahomaAll trials in PennsylvaniaAll trials in TennesseeAll trials in TexasAll trials in WashingtonAll trials in Wisconsin
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorAura Biosciences
Started2023-12-06
Est. completion2027-11-15
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations36 sites
View on ClinicalTrials.gov →
NCT06007690